首页 | 本学科首页   官方微博 | 高级检索  
     

可注射性纳米羟基磷灰石、壳聚糖复合材料修复骨缺损的实验研究
引用本文:许勇,黄智,朱立新,田京,黄锐,于博,李志浩,付国建,刘登军,冯庆玲. 可注射性纳米羟基磷灰石、壳聚糖复合材料修复骨缺损的实验研究[J]. 中国临床解剖学杂志, 2009, 27(6): 712-717. DOI: 10.13418/j.issn.1001-165x.2019.06.020
作者姓名:许勇  黄智  朱立新  田京  黄锐  于博  李志浩  付国建  刘登军  冯庆玲
作者单位:1.南方医科大学附属珠江医院骨科中心, 广州 510282; 2.清华大学材料科学与工程系, 北京 100084
基金项目:广东省自然科学基金资助(7005193)
摘    要:目的:观察可注射性羟基磷灰石/壳聚糖复合材料对兔桡骨骨缺损修复效果。方法:18只新西兰白兔双侧桡骨中段建立长度为10mm节段性缺损,将可注射性纳米羟基磷灰石/壳聚糖复合材料植入一侧骨缺损作为实验组,另一侧植入单纯羟基磷灰石材料作为对照组,于第4、8、12周末,分别行大体、X线检查、组织学、电镜检测,观察该材料对骨缺损的修复效果。结果:①大体观察、X线检查提示:实验组骨痂生长良好,骨缺损完全修复,对照组骨缺损部分修复,部分骨皮质不连续。②组织形态学: 术后12周,实验组新生骨皮质连接完整,髓腔完全再通;对照组少量新生骨形成,部分纤维组织填充③电镜检查:12周实验组材料基本降解,被新生骨组织替代。结论:可注射性纳米羟基磷灰石/壳聚糖复合材料骨缺损修复能力较单纯羟基磷灰石好,具有确实的骨缺损修复能力。

关 键 词:羟基磷灰石  壳聚糖  骨缺损  修复  
收稿时间:2009-04-02

Experimental study of injectable nano-hydroxyapatite/ chitosan composite on repairing of bone defect
XU Yong,ZHU Li-xin,TIAN Jing,et al.. Experimental study of injectable nano-hydroxyapatite/ chitosan composite on repairing of bone defect[J]. Chinese Journal of Clinical Anatomy, 2009, 27(6): 712-717. DOI: 10.13418/j.issn.1001-165x.2019.06.020
Authors:XU Yong  ZHU Li-xin  TIAN Jing  et al.
Affiliation:Department of Orthopedics, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China
Abstract:        Objective: To explore repair effects of  injectable nano-hydroxyapatite/ chitosan(nHA/CS) composite on radius bone defect. Methods: Bone defect with the length of 10 mm were created on the middle of each radius of 18 New Zealand white rabbits. the defects was filled with the nHA/CS composite as treatment group, while the others were filled with hydroxyapatite(HA) as control. The ability of repairing bone defect was evaluated by gross observation, X-ray, histopathological and SEM 4, 8, 12 weeks after operation. Results: ① The gross and X-ray showed that, in treatment group, the callus grew well and bone defect was repaired completely, oppositely, in control group, bone defect was repaired partly, with some nonunion. ② Histomorphology showed that, the new formed bone in treatment group was confirmed integral and the medullary cavity recanalized after 12 weeks, however, a little of  new  bone formed in the control group, accompanied with connective tissues growing into the defects. ③ Under the SEM, materials was replaced by newly formed bone after 12 weeks in treatment group. Conclusions: The nHA/CS has better ability of bone repairing than that of the HA.
Keywords:hydroxyapatite  chitosan  bone defect  repair
本文献已被 万方数据 等数据库收录!
点击此处可从《中国临床解剖学杂志》浏览原始摘要信息
点击此处可从《中国临床解剖学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号